Physician profile
Ly T Phan
NPI 1356430870
$3,718.04
in general payments reported to CMS, 2019-2025
21 companies · $83.79 in 2025
The $83.79 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,699 · 2020: $243 · 2021: $207 · 2022: $296 · 2023: $171 · 2024: $18.87 · 2025: $83.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,512.71 | 2019 | |
| Davol INC. | $440.26 | 2019-2022 | |
| Organogenesis INC. | $199.42 | 2020-2021 | |
| Sanofi Pasteur INC. | $74.25 | 2022-2025 | |
| 180 Medical, INC. | $68.83 | 2020-2023 | Gentlecath Glide |
| Baudax Bio INC. | $62.64 | 2020-2022 | |
| Daiichi Sankyo INC. | $61.18 | 2019-2023 | Injectafer |
| Ferring Pharmaceuticals INC. | $49.41 | 2023 | Rebyota |
| Covidien Lp | $29.39 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $29.08 | 2023 | Flumist Quadrivalent |
| Bayer Healthcare Pharmaceuticals INC. | $27.29 | 2022 | |
| Exact Sciences Corporation | $27.00 | 2025 | The Cologuard Plus Collection Kit |
| Olympus America INC. | $23.33 | 2019 | |
| Glaxosmithkline, LLC. | $21.95 | 2023 | Shingrix, Arexvy, Bexsero |
| Merck Sharp & Dohme LLC | $18.87 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $15.11 | 2025 | Kimyrsa, Orbactiv |
| Pacira Pharmaceuticals Incorporated | $13.57 | 2025 | Exparel |
| Mylan Specialty L.P. | $13.25 | 2021 | |
| Smith+Nephew, INC. | $11.29 | 2019 | |
| Medtronic, INC. | $11.18 | 2021 | |
| Endogastric Solutions, INC | $8.03 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ly Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.